IFNA1 and myeloid sarcoma: Notably, we previously observed that in the IFN-DC model, the suppression of differentiation/activation by 1,25(OH)2D3 is associated with a potent impairment of their chemotactic response [24], which could be potentially protective with respect to MS lesions.